Immune Design Corp. Available-for-sale Securities, Current
Immune Design Corp. had Available-for-sale Securities, Current of $38.85 million as of 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesCurrent · last filed 2018-11-06
- 2018-09-30: Available-for-sale Securities, Current $38.85M.
- 2018-06-30: Available-for-sale Securities, Current $46.80M.
- 2018-03-31: Available-for-sale Securities, Current $58.71M.
- 2017-12-31: Available-for-sale Securities, Current $68.65M.
| Period end | Available-for-sale Securities, Current |
|---|---|
| 2018-09-30 | $38.85M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $46.80M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $58.71M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $68.65M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $35.97M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $45.96M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $61.99M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $62.04M 10-K · filed 2018-03-14 |
| 2016-09-30 | $42.04M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $42.06M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $46.07M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-07 |